Artículos por temáticas

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG, Krismer F, Berg D, Cortelli P, Freeman R, Halliday G, Höglinger G, Lang A, Ling H, Litvan I, Lo

Mov Disord. 2022 Apr 21. doi: 10.1002/mds.29005. Online ahead of print.

Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase

Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K.

Int J Mol Sci. 2022 Apr 10;23(8):4176. doi: 10.3390/ijms23084176.

Cognitive impairment and kidney transplantation- underestimated, underrecognized but clinically relevant problem

Golenia A, Malyszko JS, Malyszko J.

Kidney Blood Press Res. 2022 Apr 21. doi: 10.1159/000521907. Online ahead of print.

Probing responses to deep brain stimulation with functional magnetic resonance imaging

Loh A, Gwun D, Chow CT, Boutet A, Tasserie J, Germann J, Santyr B, Elias G, Yamamoto K, Sarica C, Vetkas A, Zemmar A, Madhavan R, Fasano A, Lozano AM.

Brain Stimul. 2022 Apr 18:S1935-861X(22)00060-2. doi: 10.1016/j.brs.2022.03.009. Online ahead of print.

Rare tremors and tremors occurring in other neurological disorders

Erro R, Reich SG.

J Neurol Sci. 2022 Apr 15;435:120200. doi: 10.1016/j.jns.2022.120200. Epub 2022 Feb 19.

Drug-induced tremor, clinical features, diagnostic approach and management

Baizabal-Carvallo JF, Morgan JC.

J Neurol Sci. 2022 Apr 15;435:120192. doi: 10.1016/j.jns.2022.120192. Epub 2022 Feb 19.

Challenges for future theories of Parkinson pathophysiology

Darbin O, Montgomery EB Jr.

Neurosci Res. 2022 Apr;177:1-7. doi: 10.1016/j.neures.2021.11.010. Epub 2021 Nov 30.

Remote measurement and home monitoring of tremor

Mari Z, Haubenberger D.

J Neurol Sci. 2022 Apr 15;435:120201. doi: 10.1016/j.jns.2022.120201. Epub 2022 Feb 22.

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System

Yoshida K.

Toxins (Basel). 2022 Apr 14;14(4):282. doi: 10.3390/toxins14040282.

A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009

Thijssen E, den Heijer J, Puibert D, Moss L, Lei M, Hasegawa D, Keum K, Mochel K, Ezzeldin Sharaf M, Alfredson T, Zeng W, van Brummelen E, Naranda T, Groeneveld GJ.

Mov Disord. 2022 Apr;37(4):790-798. doi: 10.1002/mds.28926. Epub 2022 Jan 20.

Eye motor manifestations in children with neurometabolic disorders

Wang HP, Wong LC, Hsu CJ, Hu SC, Chu YJ, Lee WT.

J Formos Med Assoc. 2022 Apr;121(4):736-748. doi: 10.1016/j.jfma.2021.09.003. Epub 2021 Sep 22.

Functional neurological disorder: new subtypes and shared mechanisms

Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J.

Lancet Neurol. 2022 Apr 14:S1474-4422(21)00422-1. doi: 10.1016/S1474-4422(21)00422-1. Online ahead of print.

SARS-CoV-2 vaccine-related neurological complications

Oonk NGM, Ettema AR, van Berghem H, de Klerk JJ, van der Vegt JPM, van der Meulen M.

Neurol Sci. 2022 Apr;43(4):2295-2297. doi: 10.1007/s10072-022-05898-z. Epub 2022 Jan 20.

Problems and controversies in tremor classification

Louis ED, Bain PG.

J Neurol Sci. 2022 Apr 15;435:120204. doi: 10.1016/j.jns.2022.120204. Epub 2022 Feb 19.

Eye Movement Disorders in Movement Disorders

Kassavetis P, Kaski D, Anderson T, Hallett M.

Mov Disord Clin Pract. 2022 Feb 16;9(3):284-295. doi: 10.1002/mdc3.13413. eCollection 2022 Apr.